Emergent Biosolutions Inc

NYSE:EBS   4:00:00 PM EDT
12.19
+0.40 (+3.39%)
7:54:55 PM EDT: $12.35 +0.16 (+1.31%)
Earnings Announcements

Emergent Biosolutions Reports Financial Results For Third Quarter 2022

Published: 11/08/2022 23:31 GMT
Emergent Biosolutions Inc (EBS) - Emergent Biosolutions Reports Financial Results for Third Quarter 2022.
Qtrly Loss per Share $1.52.
Qtrly Adjusted Loss per Share $1.27.
Qtrly Total Revenues $790.2 Million Versus $1,069.5 Million.
Q3 Earnings per Share View $-0.06, Revenue View $268.3 Million -- Refinitiv Ibes Data (analyst estimates).
Sees FY 2022 Total Revenues Between $1,050 Million -$1,100 Million.
FY2022 Revenue View $1.20 Billion -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $297.18 Million
Adjusted EPS is expected to be $0.04

Next Quarter Revenue Guidance is expected to be $244.57 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.